T1-Substaging of Non-muscle Invasive Bladder Cancer is Associated with BCG-Failure and Improves Patient Stratification at Diagnosis.

Currently, markers are lacking that can identify high-risk non-muscle invasive bladder cancer (HR-NMIBC) patients who fail BCG-treatment. Therefore, we evaluated the prognostic value of T1-substaging in primary HR-NMIBC.